| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2001 | EP1073672A1 Antipicornaviral compounds, their preparation and use |
| 02/07/2001 | EP1073669A2 Gcp |
| 02/07/2001 | EP1073666A1 Composition for treatment of external secretion disorders except hypolacrimation |
| 02/07/2001 | EP1073664A1 (alpha-aminophosphino) peptidesderivative and compositions containing same |
| 02/07/2001 | EP1073662A1 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives |
| 02/07/2001 | EP1073658A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 02/07/2001 | EP1073657A1 Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 02/07/2001 | EP1073656A1 Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 02/07/2001 | EP1073655A1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof |
| 02/07/2001 | EP1073654A1 2,3-olefinic epothilone derivatives |
| 02/07/2001 | EP1073653A1 Novel 2-heterocyclically substituted dihydropyrimidines |
| 02/07/2001 | EP1073652A1 Paroxetine maleate |
| 02/07/2001 | EP1073651A1 Indolyl derivatives as serotonergic agents |
| 02/07/2001 | EP1073650A1 Guanidine derivatives |
| 02/07/2001 | EP1073648A1 12,13-Modified epothilone derivatives |
| 02/07/2001 | EP1073647A1 12,13-cyclopropane epothilone derivatives |
| 02/07/2001 | EP1073645A2 Process for the preparation of tetralone imines for the preparation of active pharmaceutical compounds |
| 02/07/2001 | EP1073642A1 The use of dihydropyrimidines as medicaments, and novel substances |
| 02/07/2001 | EP1073641A2 New substituted amides, their production and their use |
| 02/07/2001 | EP1073639A1 Quinoline derivatives |
| 02/07/2001 | EP1073638A1 Heterocyclically substituted amides, their production and their use |
| 02/07/2001 | EP1073637A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
| 02/07/2001 | EP1073636A1 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists |
| 02/07/2001 | EP1073635A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
| 02/07/2001 | EP1073634A1 Method for producing enantiomer-free n-methyl-n- (1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide |
| 02/07/2001 | EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 02/07/2001 | EP1073632A1 Substituted benzamides, their production and their use as cysteine protease inhibitors |
| 02/07/2001 | EP1073631A1 New substituted amides, their production and their use |
| 02/07/2001 | EP1073624A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors |
| 02/07/2001 | EP1073481A1 Solid borate-diol interaction products for use in wounds |
| 02/07/2001 | EP1073472A1 Solution for diagnosing or treating tissue pathologies |
| 02/07/2001 | EP1073471A1 Method of treating endotoxemia |
| 02/07/2001 | EP1073470A1 Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients |
| 02/07/2001 | EP1073469A1 Stable mitoxantron solutions |
| 02/07/2001 | EP1073467A2 Cosolvent formulations |
| 02/07/2001 | EP1073466A1 Solution containing nicotine |
| 02/07/2001 | EP1073455A1 Compositions and methods for extending the action of clostridial neurotoxin |
| 02/07/2001 | EP1073449A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
| 02/07/2001 | EP1073441A1 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease) |
| 02/07/2001 | EP1073440A1 sPLA 2 INHIBITOR ESTER |
| 02/07/2001 | EP1073439A1 Pharmaceutical composition |
| 02/07/2001 | EP1073438A1 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO 5,6]CYCLOHEPTA 1,2-b]PYRIDINE ORAL COMPOSITIONS |
| 02/07/2001 | EP1073437A1 Treatment of generalized anxiety disorder with paroxetine |
| 02/07/2001 | EP1073436A1 IMPROVED METHOD FOR ERADICATION OF $i(HELICOBACTER PYLORI) |
| 02/07/2001 | EP1073435A1 Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 02/07/2001 | EP1073434A1 Ccr-3 receptor antagonists |
| 02/07/2001 | EP1073433A1 Skin rash prevention composition |
| 02/07/2001 | EP1073432A2 Use of glycine site agonists or glycine uptake inhibitors for treating neuropsychiatric disorders |
| 02/07/2001 | EP1073431A1 Use of nmda antagonists for treatment of irritable bowel syndrome |
| 02/07/2001 | EP1073430A1 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
| 02/07/2001 | EP1073429A1 Aerosol formulations of salmeterol xinafoate |
| 02/07/2001 | EP1073428A1 Dihydroxyphenyl derivatives for hepatoprotection and treatment of liver diseases |
| 02/07/2001 | EP1073424A1 Pellets having a core coated with a lipid lowering agent and a polymer |
| 02/07/2001 | EP1073417A1 Pharmaceutical aerosol formulation |
| 02/07/2001 | EP1073416A1 Use of inhaled no as anti-inflammatory agent |
| 02/07/2001 | EP1073413A1 Methods and compositions for stabilizing acetylcholine compositions |
| 02/07/2001 | EP1073412A1 Skin care agents containing combinations of active agents consisting of vitamin a derivatives and ubi- or plastoquinones |
| 02/07/2001 | EP1073401A1 Topical anesthetic formulation |
| 02/07/2001 | EP1073334A1 Serotonin potentiation by oleamide analogs |
| 02/07/2001 | EP1073333A1 S-rabeprazole compositions and methods |
| 02/07/2001 | EP1073332A1 R-rabeprazole compositions and methods |
| 02/07/2001 | EP1043318A4 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity |
| 02/07/2001 | EP1033997A4 Method of mobilizing hematopoietic stem cells |
| 02/07/2001 | EP0922035B1 Tetrahydroisoquinoline derivatives and their pharmaceutical use |
| 02/07/2001 | EP0904084A4 Emergency contraceptive kit |
| 02/07/2001 | EP0799226B1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists |
| 02/07/2001 | EP0789702B1 Substituted tetracyclic oxazepine and thiazepine derivatives with 5-ht2 receptor affinity |
| 02/07/2001 | EP0789701B1 Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors |
| 02/07/2001 | EP0696921B1 Veterinary composition containing a proton pump inhibitor |
| 02/07/2001 | EP0649310B1 Stable, anticorrosive peracetic/peroxide sterilant |
| 02/07/2001 | EP0538422B1 New use of diphenylbutylpiperazinecarboxamides in the treatment of substance disorders |
| 02/07/2001 | EP0462207B1 T-pa mutants resistant to inhibition by their cognate inhibitors |
| 02/07/2001 | CN1283234A Method for suppressing multiple drug resistant in cancer cells |
| 02/07/2001 | CN1283230A Desaturated enzyme |
| 02/07/2001 | CN1283224A Hyaluronan synthase gene and uses thereof |
| 02/07/2001 | CN1283200A Androfenic Steroid compounds and method of making and using the same |
| 02/07/2001 | CN1283199A Z-halo-6-o-substituted ketolide derivatives |
| 02/07/2001 | CN1283197A Pleuromutilin derivatives as antimicrobials |
| 02/07/2001 | CN1283196A N-pheny lamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them |
| 02/07/2001 | CN1283192A Inhibition of raf kinase using aryl and hetroaryl substituted heterocyclic ureas |
| 02/07/2001 | CN1283189A Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 02/07/2001 | CN1283188A Bisulfate salt of HIV protease inhibitor |
| 02/07/2001 | CN1283186A Indole derivatives as XA factor inhibitors |
| 02/07/2001 | CN1283185A New crystalline polymorphic form of 1-methyl-5-p-toluoylpyrroel-2-acetamidoacetic acid guaiacyl ester (MED 15) |
| 02/07/2001 | CN1283184A Process for stereo selective synthesis of prostacyclin derivatives |
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/07/2001 | CN1283180A Inhibition of raf kinase using symmerical and unsymmerical substituted diphenyl ureas |
| 02/07/2001 | CN1283177A Process for the preparation of isopropyl-methyl-[2-(3-N-Propoxyphenoxy) ethyl] amine |
| 02/07/2001 | CN1283123A Sustained release medicinal compositions |
| 02/07/2001 | CN1283122A Sustained release medicinal compositions |
| 02/07/2001 | CN1283119A Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 02/07/2001 | CN1283118A Pharmaceutical grade ginseng |
| 02/07/2001 | CN1283117A Orally administrable solid ribavirin dosafe forms and process for making them |
| 02/07/2001 | CN1283116A Method of reducing craving in mamals |
| 02/07/2001 | CN1283115A Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 02/07/2001 | CN1283114A Benzoxazine compounds for enhancing synaptic response |
| 02/07/2001 | CN1283113A Medicine for treating neurodegenerative disease |
| 02/07/2001 | CN1283112A Sustained release formulation containing three different types of polymers and tablet formed therefrom |
| 02/07/2001 | CN1283111A Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |